Fermenta Biotech Limited (FERMENTA)
Updates
FY26 results (audited):
Standalone:
Revenue 47.4bn +7% y-y (44.4bn)
EBITDA 11.6bn +12% y-y (10.4bn)
EBITDA margin 24.5% (23.5%) +100 bps y-y
PAT 6.4bn +157% y-y (2.5bn)
Consolidated:
Revenue 54.8bn +6% y-y (51.5bn)
EBITDA 15.1bn +7% y-y (14.1bn)
EBITDA margin 27.6% (27.3%) +30 bps y-y
PAT 6.4bn +81% y-y (3.5bn)
Dividend: None stated
Commentary: Exceptional item in FY26 includes reversal of provision of 907.14 lakhs related to receivables.
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 FERMENTA — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add FERMENTA to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Fermenta Biotech Limited
Important.
The summary above is generated automatically from Fermenta Biotech Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.